lung cancer

Dr. Amy Sanford, an oncologist with Sanford discusses the findings of a new study that shows greater survival for newly diagnosed advanced lung cancer patients who receive an immunotherapy drug plus standard chemotherapy. These results are expected to change the way patients are treated.

Avera Leads International Lung Cancer Treatment Trial

Jan 19, 2018
Avera Health

The Avera Cancer Institute in Sioux Falls is partnering with an international research organization for a ground-breaking study of lung cancer treatment. Members of the team believe this study could help eradicate metastatic cancer by 2025.

Dr. Vladimir Lazar is the founder of the World Innovative Networking Consortium (WIN). According to Dr. Lazar, 60% of lung cancer patients are first diagnosed after the cancer has metastasized. Less than 3% of those patients survive longer than five years after their diagnosis.